Related references
Note: Only part of the references are listed.Type 2-high asthma is associated with a specific indoor mycobiome and microbiome
Louise-Eva Vandenborght et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment
Alessia Balestrini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Integrated-omics endotyping of infants with rhinovirus bronchiolitis and risk of childhood asthma
Yoshihiko Raita et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
IL-9-producing T cells: potential players in allergy and cancer
Pornpimon Angkasekwinai et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Ecological interactions in asthma: from environment to microbiota and immune responses
Ariangela Kozik et al.
CURRENT OPINION IN PULMONARY MEDICINE (2020)
Precision Microbiome Modulation with Discrete Dietary Fiber Structures Directs Short-Chain Fatty Acid Production
Edward C. Deehan et al.
CELL HOST & MICROBE (2020)
Association between probiotic supplementation and asthma incidence in infants: a meta-analysis of randomized controlled trials
Xiaochen Wei et al.
JOURNAL OF ASTHMA (2020)
Development of the Microbiota and Associations With Birth Mode, Diet, and Atopic Disorders in a Longitudinal Analysis of Stool Samples, Collected From Infancy Through Early Childhood
Gianluca Galazzo et al.
GASTROENTEROLOGY (2020)
The Role of Lung and Gut Microbiota in the Pathology of Asthma
Weronika Barcik et al.
IMMUNITY (2020)
Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis
Xinyang Song et al.
NATURE (2020)
Food for thought about manipulating gut bacteria
Nathalie M. Delzenne et al.
NATURE (2020)
Updated Evaluation of Dupilumab in the Treatment of Asthma: Patient Selection and Reported Outcomes
G. Daniel Brooks
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2020)
Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells
Clarissa Campbell et al.
NATURE (2020)
CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma
Claire Emson et al.
RESPIRATORY RESEARCH (2020)
NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
Andrew Menzies-Gow et al.
RESPIRATORY RESEARCH (2020)
Severe Asthma and Biological Therapy: When, Which, and for Whom
Paola Rogliani et al.
PULMONARY THERAPY (2020)
Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease
Merin E. Kuruvilla et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2019)
Short- and long-term real-world effectiveness of omalizumab in severe allergic asthma: systematic review of 42 studies published 2008-2018
Karen M. MacDonald et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2019)
An Update on Interleukin-9: From Its Cellular Source and Signal Transduction to Its Role in Immunopathogenesis
Sushmita Chakraborty et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Global Initiative for Asthma (GINA): 25 years later
Louis-Philippe Boulet et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Multi-Faceted Notch in Allergic Airway Inflammation
Miao-Tzu Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Leveraging -omics for asthma endotyping
Scott R. Tyler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Associations between fungal and bacterial microbiota of airways and asthma endotypes
Anukriti Sharma et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Distinct nasal airway bacterial microbiotas differentially relate to exacerbation in pediatric patients with asthma
Kathryn McCauley et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Farm-like indoor microbiota in non-farm homes protects children from asthma development
Pirkka V. Kirjavainen et al.
NATURE MEDICINE (2019)
Interspecies Competition Impacts Targeted Manipulation of Human Gut Bacteria by Fiber-Derived Glycans
Michael L. Patnode et al.
CELL (2019)
Indoor bacterial microbiota and development of asthma by 10.5 years of age
Anne M. Karvonen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype
Atul Gupta et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma
Atul Gupta et al.
PEDIATRIC PULMONOLOGY (2019)
Dietary Fiber-Induced Microbial Short Chain Fatty Acids Suppress ILC2-Dependent Airway Inflammation
Gavin Lewis et al.
FRONTIERS IN IMMUNOLOGY (2019)
Dupilumab: A Review in Moderate to Severe Asthma
Emma D. Deeks
DRUGS (2019)
Reslizumab Compared with Benralizumab in Patients with Eosinophilic Asthma: A Systematic Literature Review and Network Meta-Analysis
Thomas B. Casale et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Infant airway microbiota and topical immune perturbations in the origins of childhood asthma
Jonathan Thorsen et al.
NATURE COMMUNICATIONS (2019)
Inhaled Corticosteroid Therapy in Adult Asthma Time for a New Therapeutic Dose Terminology
Richard Beasley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
The Role of the Microbiome in Asthma: The Gut-Lung Axis
Franco Frati et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Association between the intestinal microbiota and allergic sensitization, eczema, and asthma: A systematic review
Petra Zimmermann et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Dupilumab safety and efficacy in uncontrolled asthma: a systematic review and meta-analysis of randomized clinical trials
Yazan Zayed et al.
JOURNAL OF ASTHMA (2019)
New perspectives of childhood asthma treatment with biologics
Jocelyne Just et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2019)
The upper-airway microbiota and loss of asthma control among asthmatic children
Yanjiao Zhou et al.
NATURE COMMUNICATIONS (2019)
Dupilumab for atopic dermatitis: evidence to date
Maria A. Rodrigues et al.
GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA (2019)
The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma
Giancarlo Marone et al.
FRONTIERS IN PHARMACOLOGY (2019)
Phase 2a randomized, placebo-controlled study of anti-IL-33 in peanut allergy
Sharon Chinthrajah et al.
JCI INSIGHT (2019)
Associations between infant fungal and bacterial dysbiosis and childhood atopic wheeze in a nonindustrialized setting
Marie-Claire Arrieta et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Intestinal Dysbiosis Featuring Abundance of &ITRuminococcus gnavus &ITAssociates With Allergic Diseases in Infants
Huey-Huey Chua et al.
GASTROENTEROLOGY (2018)
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
M. Castro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Quintupling Inhaled Glucocorticoids to Prevent Childhood Asthma Exacerbations
D. J. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Maternal supplementation alone with Lactobacillus rhamnosus HN001 during pregnancy and breastfeeding does not reduce infant eczema
Kristin Wickens et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2018)
Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroids
Philip Korenblat et al.
RESPIRATORY MEDICINE (2018)
Thymic Stromal Lymphopoietin Isoforms, Inflammatory Disorders, and Cancer
Gilda Varricchi et al.
FRONTIERS IN IMMUNOLOGY (2018)
RESCUE MEDICATION USE REDUCTION WITH BENRALIZUMAB FOR PATIENTS WITH SEVERE, UNCONTROLLED EOSINOPHILIC ASTHMA
S. O'Quinn et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
Targeting the Interleukin-5 Pathway for Treatment of Eosinophilic Conditions Other than Asthma
Florence Roufosse
FRONTIERS IN MEDICINE (2018)
Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma
T. B. Casale et al.
ALLERGY (2018)
Emerging pathogenic links between microbiota and the gut-lung axis
Kurtis F. Budden et al.
NATURE REVIEWS MICROBIOLOGY (2017)
Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma
Steven W. Yancey et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment
Juliana Durack et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Aberrant IgA responses to the gut microbiota during infancy precede asthma and allergy development
Majda Dzidic et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG reduces the occurrence of other allergic manifestations in children with cow's milk allergy: 3-year randomized controlled trial
Roberto Berni Canani et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Theo Vos et al.
LANCET (2017)
Tezepelumab in Adults with Uncontrolled Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Early Probiotic Supplementation for Eczema and Asthma Prevention: A Randomized Controlled Trial
Michael D. Cabana et al.
PEDIATRICS (2017)
The infant gut bacterial microbiota and risk of pediatric asthma and allergic diseases
Christine C. Johnson et al.
TRANSLATIONAL RESEARCH (2017)
Notch Ligand DLL4 Alleviates Allergic Airway Inflammation via Induction of a Homeostatic Regulatory Pathway
Miao-Tzu Huang et al.
SCIENTIFIC REPORTS (2017)
Eosinophil Activation Status in Separate Compartments and Association with Asthma
Mats W. Johansson
FRONTIERS IN MEDICINE (2017)
A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPRED
Chih-Hsi Scott Kuo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications
D. Robinson et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2017)
Characterization of asthma endotypes: implications for therapy
Jeffrey R. Stokes et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2016)
British guideline on the management of asthma: SIGN Clinical Guideline 141, 2014
David R. James et al.
ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION (2016)
Phase 3 Study of Reslizumab in Patients With Poorly Controlled Asthma Effects Across a Broad Range of Eosinophil Counts
Jonathan Corren et al.
CHEST (2016)
Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels A Randomized Phase 3 Study
Leif Bjermer et al.
CHEST (2016)
Corticosteroid therapy and airflow obstruction influence the bronchial microbiome, which is distinct from that of bronchoalveolar lavage in asthmatic airways
Darcy R. Denner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
TRPA1 channels: molecular sentinels of cellular stress and tissue damage
Felix Viana
JOURNAL OF PHYSIOLOGY-LONDON (2016)
Benralizumab, an anti-interleukin-5 receptor a monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
J. Mark FitzGerald et al.
LANCET (2016)
Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation
Kei E. Fujimura et al.
NATURE MEDICINE (2016)
Reductions in eosinophil biomarkers by benralizumab in patients with asthma
Tuyet-Hang Pham et al.
RESPIRATORY MEDICINE (2016)
How colonization by microbiota in early life shapes the immune system
Thomas Gensollen et al.
SCIENCE (2016)
Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice
David Price et al.
JOURNAL OF ASTHMA AND ALLERGY (2016)
Probiotics for prevention of atopic diseases in infants: systematic review and meta-analysis
G. Zuccotti et al.
ALLERGY (2015)
Microbiota in Allergy and Asthma and the Emerging Relationship with the Gut Microbiome
Kei E. Fujimura et al.
CELL HOST & MICROBE (2015)
The airway microbiome in patients with severe asthma: Associations with disease features and severity
Yvonne J. Huang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
The Peacekeepers
Moises Velasquez-Manoff
NATURE (2015)
Early infancy microbial and metabolic alterations affect risk of childhood asthma
Marie-Claire Arrieta et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Metabolic control of regulatory T cell development and function
Hu Zeng et al.
TRENDS IN IMMUNOLOGY (2015)
Perinatal probiotic supplementation in the prevention of allergy related disease: 6 year follow up of a randomised controlled trial
Melanie Simpson et al.
BMC DERMATOLOGY (2015)
Type 2 inflammation in asthma - present in most, absent in many
John V. Fahy
NATURE REVIEWS IMMUNOLOGY (2015)
Interaction of NPSR1 genotypes and probiotics in the manifestation of atopic eczema in early childhood
P. Kauppi et al.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2014)
Preventive effects of selected probiotic strains on the development of asthma and allergic rhinitis in childhood. The Panda study
D. M. W. Gorissen et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2014)
Supplementation with Probiotics in the First 6 Months of Life Did Not Protect against Eczema and Allergy in At-Risk Asian Infants: A 5-Year Follow-Up
Evelyn X. L. Loo et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2014)
IL-5 Triggers a Cooperative Cytokine Network That Promotes Eosinophil Precursor Maturation
Patricia C. Fulkerson et al.
JOURNAL OF IMMUNOLOGY (2014)
Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis
Aurelien Trompette et al.
NATURE MEDICINE (2014)
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
Elisabeth H. Bel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The first thousand days - intestinal microbiology of early life: establishing a symbiosis
Harm Wopereis et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2014)
Asthma Phenotypes: Nonallergic (Intrinsic) Asthma
Stephen P. Peters
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2014)
Probiotics in primary prevention of allergic disease - follow-up at 8-9 years of age
C. E. West et al.
ALLERGY (2013)
The Effects of Airway Microbiome on Corticosteroid Responsiveness in Asthma
Elena Goleva et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization?
K. Wickens et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2013)
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
Gijs den Besten et al.
JOURNAL OF LIPID RESEARCH (2013)
Structural Basis of Signaling Blockade by Anti-IL-13 Antibody Lebrikizumab
Mark Ultsch et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Yukihiro Furusawa et al.
NATURE (2013)
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Nicholas Arpaia et al.
NATURE (2013)
No effect of probiotics on respiratory allergies: a seven-year follow-up of a randomized controlled trial in infancy
Thomas R. Abrahamsson et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2013)
Probiotic Administration in Early Life, Atopy, and Asthma: A Meta-analysis of Clinical Trials
Nancy Elazab et al.
PEDIATRICS (2013)
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis
Patrick M. Smith et al.
SCIENCE (2013)
Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and meta-analysis
Meghan B. Azad et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years
C. Gore et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2012)
A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years
K. Wickens et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2012)
Prenatal and postnatal probiotics reduces maternal but not childhood allergic diseases: a randomized, double-blind, placebo-controlled trial
C. -Y. Ou et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2012)
Early probiotic supplementation for allergy prevention: Long-term outcomes
Marie P. Jensen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
IL-13 in asthma and allergic disease: Asthma phenotypes and targeted therapies
Jennifer L. Ingram et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Structure, function and diversity of the healthy human microbiome
Curtis Huttenhower et al.
NATURE (2012)
The airway epithelium in asthma
Bart N. Lambrecht et al.
NATURE MEDICINE (2012)
Real-life prospective study on asthma control in Italy: Cross-sectional phase results
Luigi Allegra et al.
RESPIRATORY MEDICINE (2012)
Lactobacillus GG treatment during pregnancy for the prevention of eczema: a randomized controlled trial
R. J. Boyle et al.
ALLERGY (2011)
Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis
L. B. van der Aa et al.
ALLERGY (2011)
Reslizumab for Poorly Controlled, Eosinophilic Asthma A Randomized, Placebo-controlled Study
Mario Castro et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy A Randomized Trial
Nicola A. Hanania et al.
ANNALS OF INTERNAL MEDICINE (2011)
Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice
Liesel D'silva et al.
CANADIAN RESPIRATORY JOURNAL (2011)
Monitoring Asthma Control in Children With Allergies by Soft Computing of Lung Function and Exhaled Nitric Oxide
Massimo Pifferi et al.
CHEST (2011)
Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples
Katherine J. Baines et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Lebrikizumab Treatment in Adults with Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Koji Atarashi et al.
SCIENCE (2011)
Use of Exhaled Nitric Oxide Measurement to Identify a Reactive, at-Risk Phenotype among Patients with Asthma
Raed A. Dweik et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Probiotics in pregnant women to prevent allergic disease: a randomized, double-blind trial
C. K. Dotterud et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Intestinal commensal bacteria promote T cell hyporesponsiveness and down-regulate the serum antibody responses induced by dietary antigen
Masato Tsuda et al.
IMMUNOLOGY LETTERS (2010)
A critical role for regulatory T cell-mediated control of inflammation in the absence of commensal microbiota
Takatoshi Chinen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Step-up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids.
Robert F. Lemanske et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Disordered Microbial Communities in Asthmatic Airways
Markus Hilty et al.
PLOS ONE (2010)
Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota
June L. Round et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
T-helper Type 2-driven Inflammation Defines Major Subphenotypes of Asthma
Prescott G. Woodruff et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
Ivaylo I. Ivanov et al.
CELL (2009)
Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort
Mikael Kuitunen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Probiotics during weaning reduce the incidence of eczema
Christina E. West et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2009)
A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma
Ana I. Caceres et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC)
C. K. W. Lai et al.
THORAX (2009)
A differential effect of 2 probiotics in the prevention of eczema and atopy: A double-blind, randomized, placebo-controlled trial
Kristin Wickens et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
The acquisition of tolerance toward cow's milk through probiotic supplementation: A randomized, controlled trial
Jeroen Hol et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
A microbial symbiosis factor prevents intestinal inflammatory disease
Sarkis K. Mazmanian et al.
NATURE (2008)
Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention:: No clinical effects of Lactobacillus GG supplementation
Matthias Volkmar Kopp et al.
PEDIATRICS (2008)
Worldwide trends in the prevalence of asthma symptoms:: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)
Neil Pearce et al.
THORAX (2007)
Severe asthma: Lessons from the Severe Asthma Research Program
Sally E. Wenzel et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial
Marko Kalliomaki et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Triggers of IgE class switching and allergy development
Lars K. Poulsen et al.
ANNALS OF MEDICINE (2007)
Impaired regulatory T cell function in germ-free mice
Sofia Ostman et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Asthma: defining of the persistent adult phenotypes
Sally E. Wenzel
LANCET (2006)
Evidence of a role of tumor necrosis factor α in refractory asthma
MA Berry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Inflammatory subtypes in asthma: Assessment and identification using induced sputum
JL Simpson et al.
RESPIROLOGY (2006)
Influence of intestinal bacteria on induction of regulatory T cells:: lessons from a transfer model of colitis
UG Strauch et al.
GUT (2005)
An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system
SK Mazmanian et al.
CELL (2005)
Use of exhaled nitric oxide measurements to guide treatment in chronic asthma
AD Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The hygiene hypothesis of atopic disease - An extended version
S Rautava et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2004)
Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma
R Djukanovic et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway
PT Flood-Page et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders
ES Schulman
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Asthma severity and inflammation markers in children
NM Wilson et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2001)
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
MJ Leckie et al.
LANCET (2000)
Share Paper
